GENE ONLINE|News &
Parexel Acquires Vitrana to Integrate AI-Enabled Pharmacovigilance Solutions
Parexel has acquired Vitrana in a move to broaden its pharmacovigilance technology platform. The acquisition aims to integrate artificial intelligence-enabled pharmacovigilance solutions with Parexel’s existing clinical and safety services.
The acquisition will incorporate Vitrana’s AI-driven solutions into Parexel’s services. This integration seeks to enhance the efficiency and capabilities of Parexel’s pharmacovigilance operations by leveraging Vitrana’s technological advancements.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: April 30, 2026
©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
LATEST
Digitalis Glycosides Studied for Heart Failure Treatment at ESC Heart Failure 2026 Congress
2026-05-10
Digoxin Lowers Death Risk and Heart Failure in Rheumatic Heart Disease Patients, Study Finds
2026-05-10
New Test Detects Biomarkers for Frontotemporal Lobar Degeneration, a Rare Dementia Affecting Over 57 Million Globally
2026-05-10
